Company registration number 02571923 (England and Wales)
INJECTION CORRECTION UK LIMITED
UNAUDITED FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
PAGES FOR FILING WITH REGISTRAR
INJECTION CORRECTION UK LIMITED
CONTENTS
Page
Balance sheet
1
Notes to the financial statements
2 - 4
INJECTION CORRECTION UK LIMITED
BALANCE SHEET
AS AT 31 DECEMBER 2024
31 December 2024
- 1 -
2024
2023
Notes
£
£
£
£
Capital and reserves
Called up share capital
4
7,915
7,915
Share premium account
5
195,750
195,750
Capital redemption reserve
5
1,000
1,000
Profit and loss reserves
5
(204,665)
(204,665)
Total equity
-
0
-
0

The director of the company has elected not to include a copy of the profit and loss account within the financial statements.true

For the financial year ended 31 December 2024 the company was entitled to exemption from audit under section 480 of the Companies Act 2006 relating to dormant companies.

The director acknowledges his responsibilities for complying with the requirements of the Companies Act 2006 with respect to accounting records and the preparation of financial statements.

The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476.

These financial statements have been prepared and delivered in accordance with the provisions applicable to companies subject to the small companies regime.

The financial statements were approved and signed by the director and authorised for issue on 26 September 2025
I L Turner
Director
Company Registration No. 02571923
INJECTION CORRECTION UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS
FOR THE YEAR ENDED 31 DECEMBER 2024
- 2 -
1
Accounting policies
Company information

Injection Correction UK Limited is a private company limited by shares incorporated in England and Wales. The registered office is Little Oak Drive, Sherwood Park, Annesley, Nottinghamshire, NG15 0DR.

1.1
Accounting convention

These financial statements have been prepared in accordance with FRS 102 “The Financial Reporting Standard applicable in the UK and Republic of Ireland” (“FRS 102”) and the requirements of the Companies Act 2006 as applicable to companies subject to the small companies regime. The disclosure requirements of section 1A of FRS 102 have been applied other than where additional disclosure is required to show a true and fair view.

The financial statements are prepared in sterling, which is the functional currency of the company. Monetary amounts in these financial statements are rounded to the nearest £.

1.2
Profit and loss account

The company has not traded during the year or the preceding financial period. During this time, the company received no income and incurred no expenditure and therefore no Profit and loss account is presented in these financial statements.

1.3
Financial instruments

The company has elected to apply the provisions of Section 11 ‘Basic Financial Instruments’ and Section 12 ‘Other Financial Instruments Issues’ of FRS 102 to all of its financial instruments.

 

Financial instruments are recognised in the company's balance sheet when the company becomes party to the contractual provisions of the instrument.

 

Financial assets and liabilities are offset, with the net amounts presented in the financial statements, when there is a legally enforceable right to set off the recognised amounts and there is an intention to settle on a net basis or to realise the asset and settle the liability simultaneously.

Basic financial assets

Basic financial assets, which include debtors and cash and bank balances, are initially measured at transaction price including transaction costs and are subsequently carried at amortised cost using the effective interest method unless the arrangement constitutes a financing transaction, where the transaction is measured at the present value of the future receipts discounted at a market rate of interest. Financial assets classified as receivable within one year are not amortised.

Classification of financial liabilities

Financial liabilities and equity instruments are classified according to the substance of the contractual arrangements entered into. An equity instrument is any contract that evidences a residual interest in the assets of the company after deducting all of its liabilities.

INJECTION CORRECTION UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
1
Accounting policies
(Continued)
- 3 -
Basic financial liabilities

Basic financial liabilities, including creditors, bank loans, loans from fellow group companies and preference shares that are classified as debt, are initially recognised at transaction price unless the arrangement constitutes a financing transaction, where the debt instrument is measured at the present value of the future payments discounted at a market rate of interest. Financial liabilities classified as payable within one year are not amortised.

 

Debt instruments are subsequently carried at amortised cost, using the effective interest rate method.

 

Trade creditors are obligations to pay for goods or services that have been acquired in the ordinary course of business from suppliers. Amounts payable are classified as current liabilities if payment is due within one year or less. If not, they are presented as non-current liabilities. Trade creditors are recognised initially at transaction price and subsequently measured at amortised cost using the effective interest method.

1.4
Equity instruments

Equity instruments issued by the company are recorded at the proceeds received, net of transaction costs. Dividends payable on equity instruments are recognised as liabilities once they are no longer at the discretion of the company.

2
Judgements and key sources of estimation uncertainty

In the application of the company’s accounting policies, the director is required to make judgements, estimates and assumptions about the carrying amount of assets and liabilities that are not readily apparent from other sources. The estimates and associated assumptions are based on historical experience and other factors that are considered to be relevant. Actual results may differ from these estimates.

 

The estimates and underlying assumptions are reviewed on an ongoing basis. Revisions to accounting estimates are recognised in the period in which the estimate is revised where the revision affects only that period, or in the period of the revision and future periods where the revision affects both current and future periods.

3
Employees

The average monthly number of persons (including directors) employed by the company during the year was:

2024
2023
Number
Number
Total
1
1
4
Called up share capital
2024
2023
2024
2023
Ordinary share capital
Number
Number
£
£
Issued and fully paid
Ordinary of £1 each
7,915
7,915
7,915
7,915
INJECTION CORRECTION UK LIMITED
NOTES TO THE FINANCIAL STATEMENTS (CONTINUED)
FOR THE YEAR ENDED 31 DECEMBER 2024
- 4 -
5
Reserves
Share premium

The share premium account represents the excess paid on the nominal value of shares repurchased by the company.

Capital redemption reserve

The capital redemption reserve relates to the company's acquisition of its own shares.

Share capital

This represents the nominal value of shares repurchased by the company.

Profit and loss reserves

The profit and loss account represents all other net gains and losses and transactions with owners (e.g. dividends) not recognised elsewhere.

6
Parent company

The company's immediate parent undertaking is Standard Motor Products Europe Limited and the ultimate parent undertaking is Standard Motor Products Holdings Ltd, a company registered in the UK.

Standard Motor Products Holdings Ltd is ultimately controlled by I L Turner and M Turner.

 

Standard Motor Products Holdings Limited is the largest and smallest group for which consolidated accounts are prepared, copies of which can be obtained from Companies House, Cardiff, CF14 3UZ.

2024-12-312024-01-01falsefalsetrue26 September 2025CCH SoftwareCCH Accounts Production 2025.100No description of principal activityI L Turner025719232024-01-012024-12-31025719232024-12-3102571923core:ShareCapital2024-12-3102571923core:ShareCapital2023-12-3102571923core:SharePremium2024-12-3102571923core:SharePremium2023-12-3102571923core:CapitalRedemptionReserve2024-12-3102571923core:CapitalRedemptionReserve2023-12-3102571923core:RetainedEarningsAccumulatedLosses2024-12-3102571923core:RetainedEarningsAccumulatedLosses2023-12-31025719232023-12-3102571923core:ShareCapitalOrdinaryShareClass12024-12-3102571923core:ShareCapitalOrdinaryShareClass12023-12-3102571923bus:Director12024-01-012024-12-31025719232023-01-012023-12-3102571923bus:OrdinaryShareClass12024-01-012024-12-3102571923bus:OrdinaryShareClass12024-12-3102571923bus:OrdinaryShareClass12023-12-3102571923bus:EntityHasNeverTraded2024-01-012024-12-3102571923bus:PrivateLimitedCompanyLtd2024-01-012024-12-3102571923bus:SmallCompaniesRegimeForAccounts2024-01-012024-12-3102571923bus:FRS1022024-01-012024-12-3102571923bus:AuditExemptWithAccountantsReport2024-01-012024-12-3102571923bus:FullAccounts2024-01-012024-12-31xbrli:purexbrli:sharesiso4217:GBP